Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 1 |
2017 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14.
N Engl J Med. 2017.
PMID: 28910237
Free PMC article.
Clinical Trial.
Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain.
Forst T, Smith T, Schütte K, Marcus P, Pfützner A; CNS 5161 Study Group.
Forst T, et al.
Br J Clin Pharmacol. 2007 Jul;64(1):75-82. doi: 10.1111/j.1365-2125.2007.02880.x. Epub 2007 Mar 28.
Br J Clin Pharmacol. 2007.
PMID: 17391323
Free PMC article.
Item in Clipboard
Cite
Cite